August 13, 2002
Patient Benefits Drive Growth in Computer-Assisted Surgery
FOOTHILL RANCH, Calif., August 13 /PRNewswire/ -- Growth in the market for devices and systems related to computer-aided surgery (CAS) is being driven in great part by the gains realized in patient benefits, according to the August 2002 issue of “MedMarkets.” “Gains in this $600 million market are expected to be substantial, with the market will likely reach $2.6 billion by 2010,” said Patrick J. Driscoll, Publisher of “MedMarkets.” CAS is directly driving procedure growth, especially for minimally invasive procedures, and is driving growth in the market for virtual reality training systems and pre-operative planning, as well as for intraoperative visualization, according to Driscoll.
The largest CAS segment, which is also growing fastest, is for systems and equipment related to medical imaging and computer-aided diagnosis. The companies involved in this industry are many and varied—Analyze Direct, Bioluminate, Bonecraft, BrainLAB, CASurgica, CARCAS Group, Cedera, GE, Given Imaging, The Interventional Centre, Intuitive Surgical, Invivo Research, Interactive Visualization Systems, Karl Storz, Khoral Research, MISON, Motion Analysis, Olympus America, Stryker, Vasamedics, Vista Medical Technologies, Vaytek, and Volume Interactions.
Related market segments are growing as well, including image processing and display; robotics and instrument guiding systems; surgical simulation and education; computer-assisted therapy; and operating room management and telemedicine.
Also covered in the August issue of MedMarkets is the recent innovation in arthroscopy for hip and knee replacement. In particular, the market for unicompartmental knee replacement devices is expected to grow from just 5,000 units two years ago to between 20,000 and 25,000 this year. The key companies leading this market include: Biomet; Zimmer; and Centerpulse (formerly SulzerMedica). In addition, Zimmer and Stryker Howmedica Osteonics are competing for position in the market for minimally invasive total knee replacements.
“MedMarkets,” published by MedMarket Diligence, analyzes the market and clinical practice implications of developments in medical technology--medical devices, equipment and supplies as well as biomaterials, biotech, pharmaceutical, e-health and others. In addition to “MedMarkets,” the company publishes dedicated market/technology reports, and is developing other information solutions. For more information on “MedMarkets” or MedMarket Diligence, LLC, visit the Web site at www.mediligence.com to view a sample issue in its entirety.
Contact: Patrick J. Driscoll, (949) 859-3401, or e-mail.